By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Sientra Inc is a part of the healthcare sector in the United States. Its business involves the provision of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. Its operating segments are Breast Products and miraDry. The Breast Products segment focuses on sales of breast implants, tissue expanders and scar management products under the brands' OPUS, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System and bioTips. Geographically, the firm generates a majority of its revenue from the United States.

Contact Information

Website: www.sientra.com
Email: IR@sientra.com
Main Phone: +1 805 562-3500
Address: 420 South Fairview Avenue
Address 2: Suite 200
State: CA
City / Town: Santa Barbara
Country: US
Postal Code: 93117

Issuer Information

Exchange: NGS
CEO: Ronald Menezes
Employees: 255
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A